ExL Pharmaceutical Pricing and Reimbursement Conference

Jul. 26, 2010-Jul. 27, 2010
Bridgewater Marriott
Bridgewater, NJ
www.exlpharma.com/events/pharmaceutical-pricing-reimbursement

Description:

Lujing Wang, a Vice President in our Managed Markets Practice, will present a session on "Evidence-Based Medicine in an Evolving Landscape for Global Market Access."

Abstract:

Evidence-Based Medicine in an Evolving Landscape for Global Market Access

Speaker:
Lujing Wang, Vice President, Campbell Alliance

The global landscape for market access is evolving and there are major trends taking hold that are reshaping the way payers and reimbursement bodies make reimbursement and coverage decisions.  In order to survive in this evolving environment, pharmaceutical companies must re-evaluate their current approach to access decision making, and begin thinking more strategically about how to address market access challenges.  This session will discuss   

  • The major trends that are shaping the global market access landscape
  • Key market access barriers and how they vary by geographic market and disease area 
  • Increasing focus on evidence based medicine and HTA
  • The evolving requirement for evidence to support product reimbursement and access
  • How these trends are shaping pharmaceutical markets and how the evidence base is coming
  • Implications for pharmaceutical companies:
    • Overcoming the growing requirements and sophistication of payers require that companies think more strategically about how to address market access challenges
    • Better integrating evidence generation and value substantiation into the commercial planning process  
  • Key Takeaways for commercial planners

View Entire Event Calendar

Don't Miss